SAN DIEGO, January 4, 2022 — Artiva Biotherapeutics, Inc., an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, today announced the appointment of Christopher Horan as Chief Technical Operations Officer. As a leader in therapeutic technical operations, Mr. Horan brings more than 30 years of experience managing…
